GlassScriptPhysician profile
Matthew A Miller
NPI 1235691841
$5,133.09
in general payments reported to CMS, 2019-2025
14 companies · $632 in 2025
The $632 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $117 · 2021: $914 · 2022: $1,170 · 2023: $844 · 2024: $1,456 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,932.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,335.91 | 2020-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $832.13 | 2021-2024 | |
| Sientra, INC. | $519.13 | 2021-2022 | |
| Davol INC. | $477.22 | 2022-2025 | Arista, Arista Ah Flexitip, Phasix Mesh |
| Rti Surgical, INC | $440.39 | 2024-2025 | |
| Polynovo North America LLC | $364.42 | 2022-2024 | Novosorb Btm |
| Tela Bio, INC. | $263.81 | 2021-2022 | |
| Abbvie INC. | $200.45 | 2024-2025 | |
| Mesh Suture INC | $194.01 | 2024 | |
| Integra Lifesciences Corporation | $171.02 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Innovation Technologies INC | $170.70 | 2021-2023 | Irrisept |
| Baxter Healthcare | $79.66 | 2021 | |
| Genmab U.S., INC. | $58.09 | 2024 | Tivdak |
| Allergan, INC. | $26.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.